I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Undervalued Stocks on AMEX
Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.
In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on AMEX
Today’s data is for companies listed on the American Stock Exchange.
Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
---|---|---|---|---|---|---|
CQP | Cheniere Energy Partners LP | 2017 | 31.580000 | 37.0000 | USD | 3 |
TXMD | TherapeuticsMD Inc | 2017 | 6.760000 | 24.5000 | USD | 2 |
MAG | MAG Silver Corp | 2017 | 14.220000 | 24.7627 | CAD | 9 |
PARR | Par Pacific Holdings Inc | 2017 | 15.600000 | 23.0000 | USD | 1 |
SAND | Sandstorm Gold Ltd | 2017 | 4.400000 | 7.5357 | CAD | 7 |
REI | Ring Energy Inc | 2017 | 10.150000 | 17.1667 | USD | 3 |
STRP | Straight Path Communications Inc | 2017 | 33.000000 | 56.0000 | USD | 1 |
MTNB | Matinas BioPharma Holdings Inc | 2017 | 3.500000 | 7.0000 | USD | 2 |
BRG | Bluerock Residential Growth REIT Inc | 2017 | 11.540000 | 16.0000 | USD | 3 |
ESTE | Earthstone Energy Inc | 2017 | 12.000000 | 18.0000 | USD | 3 |
OCX | OncoCyte Corp | 2017 | 4.950000 | 10.0000 | USD | 1 |
SPP | Sanchez Production Partners LP | 2017 | 12.900000 | 17.0000 | USD | 1 |
MCF | Contango Oil & Gas Co | 2017 | 6.180000 | 11.5000 | USD | 2 |
VISI | Volt Information Sciences Inc | 2017 | 7.200000 | 14.0000 | USD | 1 |
AST | Asterias Biotherapeutics Inc | 2017 | 3.150000 | 12.0000 | USD | 1 |
UUUU | Energy Fuels Inc | 2017 | 1.960000 | 6.4473 | CAD | 1 |
USAPF | Americas Silver Corp | 2017 | 3.190000 | 7.5000 | CAD | 3 |
DLA | Delta Apparel Inc | 2017 | 16.040000 | 26.0000 | USD | 1 |
BGSF | BG Staffing Inc | 2017 | 14.020000 | 19.0000 | USD | 1 |
VNRX | VolitionRX Ltd | 2017 | 4.550000 | 8.5000 | USD | 2 |
UFAB | Unique Fabricating Inc | 2017 | 11.180000 | 17.0000 | USD | 1 |
SYN | Synthetic Biologics Inc | 2017 | 0.769900 | 7.0000 | USD | 1 |
CRMD | Cormedix Inc | 2017 | 2.150000 | 6.5000 | USD | 1 |
PTN | Palatin Technologies Inc | 2018 | 0.339000 | 3.7500 | USD | 2 |
JOB | GEE Group Inc | 2017 | 4.670000 | 10.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
MTNB:ASE Matinas BioPharma Hldgs
http://www.matinasbiopharma.com
Matinas BioPharma Hldgs has 10 employees and is headquartered in United States.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
BRG:ASE Bluerock Residential
http://www.bluerockresidential.com
Bluerock Residential has None employees and is headquartered in United States.
Bluerock Residential Growth REIT Inc invests in institutional-quality apartment properties in US growth markets. The Company’s objective is to maximize returns through investments in Class A institutional-quality apartment properties in United States.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.